Hong Kong-based InsurTech company, MediConCen, has secured $6.85 million in Series A funding to support its expansion plans in international markets, particularly in the Middle East and Southeast Asia. MediConCen uses AI and blockchain technology to automate insurance claims and streamline the claims process. The latest funding round was led by HSBC Asset Management and included support from existing investors G&M Capital and ParticleX, as well as new investor Wings Capital Ventures. With this funding, MediConCen’s total funding now stands at $12.7 million.
Hong Kong’s MediConCen Scores Impressive $685m in InsurTech Funding
Latest from Blog
Driving Global Growth with Venture Capital and Private Equity
TLDR: Venture Capital (VC) and Private Equity (PE) are vital for driving innovation and economic growth globally. Breakthrough technologies, global market access, evolving consumer behavior, supportive regulations, and institutional investor participation are
SoSoValue Raises $415M Seed Funding
TLDR: Singapore-based AI-driven investment research startup SoSoValue secures $4.15 million in seed funding. The round was led by HongShan and included contributions from GSR Markets, Alumni Ventures, and CoinSummer Labs. Singapore-based AI-driven
Pasha Romanovski’s Departure from Hanaco Ventures Sparks Industry Buzz
TLDR: Pasha Romanovski is leaving VC firm Hanaco Ventures after eight years. Romanovski has been involved in recent scandals with companies in which he invested, including Vesttoo and Infarm. After eight years
Diversification: Middle Eastern Investors Back Southeast Asia PE Funds
TLDR: – Middle East investors are diversifying their portfolios by backing Southeast Asia-focused PE funds – TVM Capital Healthcare has closed its second Middle East fund, drawing US$250 million from institutional investors
Diving Into China’s Freezing Venture Capital Winter and IPO Market
TLDR: China’s IPO market is facing difficulties, with a significant drop in the total value and number of companies going public. Geopolitical tensions and sluggish IPOs have led to a challenging venture